{"name": "BiOxyDyn",
 "permalink": "bioxydyn",
 "crunchbase_url": "http://www.crunchbase.com/company/bioxydyn",
 "homepage_url": "http://www.bioxydyn.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "BiOxyDyn",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2009,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@bioxydyn.com",
 "phone_number": "44-(0)161-660-7007",
 "description": "",
 "created_at": "Thu Oct 04 10:09:31 UTC 2012",
 "updated_at": "Sat Mar 30 19:55:09 UTC 2013",
 "overview": "\u003Cp\u003EBiOxyDyn is a company specialising in the development and application of new diagnostic imaging tools and imaging services. Their portfolio of technologies and capabilities includes imaging tools to improve the understanding of lung diseases such as chronic obstructive pulmonary disease (COPD) and asthma. They are also active in the development of new imaging tools for oncology and neuroscience.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       58],
      "assets/images/resized/0021/4194/214194v1-max-150x150.jpg"],
     [[250,
       97],
      "assets/images/resized/0021/4194/214194v1-max-250x250.jpg"],
     [[340,
       133],
      "assets/images/resized/0021/4194/214194v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "\u00a31.2M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.finsmes.com/2012/10/bioxydyn-secures-1-2m-investment.html?utm_source=feedburner\u0026utm_medium=feed\u0026utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29",
    "source_description": "BiOxyDyn Secures \u00a31.2M Investment",
    "raised_amount": 1200000.0,
    "raised_currency_code": "GBP",
    "funded_year": 2012,
    "funded_month": 10,
    "funded_day": 4,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "North West Fund",
         "permalink": "north-west-fund",
         "image":
          {"available_sizes":
            [[[150,
               46],
              "assets/images/resized/0012/7217/127217v1-max-150x150.jpg"],
             [[250,
               77],
              "assets/images/resized/0012/7217/127217v1-max-250x250.jpg"],
             [[308,
               95],
              "assets/images/resized/0012/7217/127217v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "MTI",
         "permalink": "mti",
         "image":
          {"available_sizes":
            [[[150,
               84],
              "assets/images/resized/0007/2865/72865v2-max-150x150.png"],
             [[250,
               140],
              "assets/images/resized/0007/2865/72865v2-max-250x250.png"],
             [[297,
               167],
              "assets/images/resized/0007/2865/72865v2-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "Rutherford House",
    "address2": "Pencroft Way",
    "zip_code": "M15 6SZ ",
    "city": "Manchester",
    "state_code": null,
    "country_code": "GBR",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        99],
       "assets/images/resized/0021/4195/214195v1-max-150x150.jpg"],
      [[250,
        165],
       "assets/images/resized/0021/4195/214195v1-max-250x250.jpg"],
      [[450,
        298],
       "assets/images/resized/0021/4195/214195v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}